Beckman Coulter Diagnostics announces a €10 million investment and 80 jobs in Mid-West Ireland
Beckman Coulter Diagnostics, the largest employer in East Clare and among the largest in the county, has announced a €10 million investment at its high-tech site at O´Callaghan´s Mills that underscores the company’s commitment to innovation and growth in the region. The investment will enhance Beckman Coulter’s world-class diagnostics production with the addition of two new fully automated reagent filling lines and upgrades to the site’s infrastructure, boosting both efficiency and capacity.
The company is actively hiring for 50 open roles and also announced 30 additional jobs arising, to be recruited between 2025 and 2027 for highly-skilled professionals at its Co. Clare facility for key functions such as Production Operations, Quality & Regulatory Affairs, Research & Development, etc.
Beckman Coulter’s economic contribution is highly significant to East Clare and the wider Mid-West region thanks to the 550 plus jobs it provides in its facility. Employment at the site is anticipated to rise to 600 jobs, with headcount figures having almost doubled since 2018.
An economic impact assessment carried out by independent market research experts Repucon revealed that the economic impact of the company was €183 million based on annual GVA (Gross Value Added) in 2023. The report also shows that the Employment Income Impact of the company for the regional economy in 2023 was €55 million, of which €22 million is provided through its 220 plus employees living in Co. Clare. Over the next five years, Beckman Coulter’s regional employment income impact is projected to generate €380 million.
Beckman Coulter is a shining example of how cutting-edge foreign direct investment in Ireland can coexist in harmony with its precious environment. In fact, beyond its people, the company also recognises its responsibilities to local farmland, with its 15,900 sq m facility located within a 120 Ha farmland. A focus on sustainability at the site has led to the company making use of renewable energy, as well as a wormery waste treatment plant, water treatment plant, development of a 5 km nature trail, and supporting the farmland ecosystem with over 240,000 bees living on-site.
“I’m incredibly happy about Beckman Coulter’s significant contributions to my home country, Ireland, not only to the local economy but also to enhancing healthcare every day,” said Kevin O’Reilly, Beckman Coulter’s Ireland-born president, who was appointed earlier this year to lead the company and its 11,000 employees globally.
Mary Buckley, Executive Director of IDA Ireland, said: “Beckman Coulter has had a presence in Co. Clare since 2005. The announcement of a €10 million expansion is very welcome news and exemplifies IDA Ireland’s continued commitment to winning jobs and investment for every region in Ireland. I wish Beckman Coulter continued success.”
One of the top 3 diagnostics companies worldwide, Beckman Coulter Diagnostics employs over 11,000 people all over the world and plays a major role in world health. Every hour around the world, more than 1 million samples – representing up to 1 million people – are analysed in hospitals using Beckman Coulter instruments. In Ireland, hospitals in Cork, Kerry, and Mayo are prime examples of facilities using Beckman Coulter’s instruments.
